Aldosterone Blockade in Chronic Kidney Disease. Influence on Arterial Stiffness and Kidney Function.
Phase of Trial: Phase III
Latest Information Update: 07 Feb 2012
At a glance
- Drugs Eplerenone (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- Acronyms ALBLOCK-2
- 07 Feb 2012 Actual patient number (54) added as reported by ClinicalTrials.gov.
- 07 Feb 2012 Planned end date changed from 1 Apr 2012 to 1 Feb 2012 as reported by ClinicalTrials.gov.
- 07 Feb 2012 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.